This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: COMMANDER

October 2018 Br J Cardiol 2018;25:135–7

News from ESC 2018: COMMANDER HF – rivaroxaban in heart failure…

BJC Staff

Abstract

European Society of Cardiology congress 2018, held in Munich This was the key finding from COMMANDER HF (A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction, or Stroke in Participants with Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure) presented in a Hot Line Session and also published in The New England Journal of Medicine (DOI: 10.1056/NEJMoa1808848). Patients with worsening heart failure experience high rates of hospital readmission, and death. Previous studies have suggested that the enzyme thrombin may contribute to these poor o

| Full text

For healthcare professionals only

Add Banner

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now